Literature DB >> 26865179

Artesunate attenuates unilateral ureteral obstruction-induced renal fibrosis by regulating the expressions of bone morphogenetic protein-7 and uterine sensitization-associated gene-1 in rats.

Jing Cao1,2, Wei Wang2,3, Yong Li4, Jieyun Xia2, Yingxian Peng1,2, Yaqian Zhang1,2, Anzhou Xia5.   

Abstract

PURPOSE: Kidney fibrosis is the most common final stage of progressive renal disease. Bone morphogenetic protein-7 (BMP-7) has been shown to be important in both preservation of kidney function and resistance to injury. Recently, it has been realized that uterine sensitization-associated gene-1 (USAG-1) functions as a kidney-specific BMP antagonist. Because of the reported anti-fibrotic effects of artesunate (Art), this study was designed to investigate the effects of Art on renal fibrosis in unilateral ureteral obstruction (UUO) rats and to explore the underlying mechanisms.
METHODS: Thirty male Sprague-Dawley rats were randomly divided into five groups: Sham group, UUO group, low-dose Art-treated (Art-L), middle-dose Art-treated (Art-M), and high-dose Art-treated (Art-H) groups. The UUO rat model was established by ligating the left ureter. Fourteen days later, interstitial collagen deposition, expression of USAG-1, BMP-7, E-cadherin, α-smooth muscle actin (α-SMA), fibronectin (FN), collagen I, as well as the inflammatory infiltration levels in the kidneys were assessed.
RESULTS: Art treatment significantly attenuated the deposition of interstitial collagens in the UUO rats' kidneys and exhibited the ability to improve renal function, followed by the up-regulated expression of BMP-7 and E-cadherin and the down-regulated expression of USAG-1 and α-SMA. In addition, increased macrophages infiltration in the kidneys of the UUO rats were also attenuated by the administration of Art.
CONCLUSIONS: These results indicate that Art is able to improve the renal function decline and renal fibrosis induced by UUO, which may be associated with the up-regulation of BMP-7 and down-regulation of USAG-1. Accordingly, Art may become a potential preventive or therapeutic agent for chronic kidney diseases.

Entities:  

Keywords:  Artesunate; Bone morphogenetic protein-7; Renal fibrosis; Unilateral ureteral obstruction; Uterine sensitization-associated gene-1

Mesh:

Substances:

Year:  2016        PMID: 26865179     DOI: 10.1007/s11255-016-1232-0

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  31 in total

Review 1.  Modulator of bone morphogenetic protein activity in the progression of kidney diseases.

Authors:  M Yanagita
Journal:  Kidney Int       Date:  2006-07-26       Impact factor: 10.612

Review 2.  Chronic kidney disease.

Authors:  Andrew S Levey; Josef Coresh
Journal:  Lancet       Date:  2011-08-15       Impact factor: 79.321

Review 3.  Renal interstitial fibrosis: mechanisms and evaluation.

Authors:  Alton B Farris; Robert B Colvin
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

4.  Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction.

Authors:  K A Hruska; G Guo; M Wozniak; D Martin; S Miller; H Liapis; K Loveday; S Klahr; T K Sampath; J Morrissey
Journal:  Am J Physiol Renal Physiol       Date:  2000-07

Review 5.  Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator.

Authors:  Fuad N Ziyadeh
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

6.  Artesunate restraining MAPK passage by smad7 to resist pulmonary fibrosis.

Authors:  H-X Li; H Liu; C-M Wang; H-J Wang; J Chen
Journal:  Eur Rev Med Pharmacol Sci       Date:  2014       Impact factor: 3.507

7.  Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors.

Authors:  Hikaru Sugimoto; Gordan Grahovac; Michael Zeisberg; Raghu Kalluri
Journal:  Diabetes       Date:  2007-04-24       Impact factor: 9.461

Review 8.  Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy.

Authors:  Robert L Chevalier; Michael S Forbes; Barbara A Thornhill
Journal:  Kidney Int       Date:  2009-04-01       Impact factor: 10.612

9.  USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney.

Authors:  Motoko Yanagita; Masako Oka; Tetsuro Watabe; Haruhisa Iguchi; Atsushi Niida; Satoru Takahashi; Tetsu Akiyama; Kohei Miyazono; Masashi Yanagisawa; Takeshi Sakurai
Journal:  Biochem Biophys Res Commun       Date:  2004-04-02       Impact factor: 3.575

10.  Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia.

Authors:  Rithea Leang; Sakun Ros; Socheat Duong; Visweswaran Navaratnam; Pharath Lim; Frédéric Ariey; Jean-René Kiechel; Didier Ménard; Walter R J Taylor
Journal:  Malar J       Date:  2013-09-23       Impact factor: 2.979

View more
  7 in total

Review 1.  Uterine Sensitization-Associated Gene-1 in the Progression of Kidney Diseases.

Authors:  Xiaohu Li; Wenlong Yue; Guiwen Feng; Jinfeng Li
Journal:  J Immunol Res       Date:  2021-08-07       Impact factor: 4.818

Review 2.  Therapeutic Implications of Ferroptosis in Renal Fibrosis.

Authors:  Yao Zhang; Yanhua Mou; Jianjian Zhang; Chuanjian Suo; Hai Zhou; Min Gu; Zengjun Wang; Ruoyun Tan
Journal:  Front Mol Biosci       Date:  2022-05-17

3.  Effect of artesunate and relation with TGF-β1 and SMAD3 signaling on experimental hypertrophic scar model in rabbit ear.

Authors:  Xiaolin Nong; Girju Rajbanshi; Ling Chen; Jiaquan Li; Zhan Li; Taotao Liu; Shihai Chen; Gao Wei; Jushang Li
Journal:  Arch Dermatol Res       Date:  2019-08-09       Impact factor: 3.017

4.  Artesunate prevents knee intraarticular adhesion via PRKR-like ER kinase (PERK) signal pathway.

Authors:  Hui Chen; Jin Tao; Jingcheng Wang; Lianqi Yan
Journal:  J Orthop Surg Res       Date:  2019-12-17       Impact factor: 2.359

Review 5.  Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics.

Authors:  David Dolivo; Pamela Weathers; Tanja Dominko
Journal:  Acta Pharm Sin B       Date:  2020-09-08       Impact factor: 11.413

6.  Role of artesunate in TGF‑β1‑induced renal tubular epithelial‑mesenchymal transdifferentiation in NRK‑52E cells.

Authors:  Yaqian Zhang; Huanhuan Li; Jiajun Zhu; Tiantian Wei; Yingxian Peng; Ran Li; Rui Xu; Mei Li; Anzhou Xia
Journal:  Mol Med Rep       Date:  2017-10-05       Impact factor: 2.952

Review 7.  The Therapeutic Effect of Artemisinin and Its Derivatives in Kidney Disease.

Authors:  Ming Xia; Di Liu; Yu Liu; Hong Liu
Journal:  Front Pharmacol       Date:  2020-03-31       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.